1Lee SK, Park DC, Kim MG, et al. Rate of isolation andtrends of antimicrobial resistance of multidrug resistantpseudomonas aeruginosa from otorrhea in chronic suppu-rative otitis media[J]. Clin Exp Otorhinolaryngol, 2012, 5(1):17-22.
2Si Y,Zhang ZG’Chen SJ,et al. Attenuated TLRs in mid-dle ear mucosa contributes to susceptibility of chronicsuppurative otitis media[J]. Hum Immunol,2014,75 (8):771-776.
3Chang J,Lee SH,Choi J,et al. Nasopharynx as amicrobio-logic reservoir in chronic suppurative otitis media:prelimi-nary study[J]. Clin Exp Otorhinolaryngol? 2011,4(3):122-125.
4Albert RR,Job A,Kuruvilla G,et al. Outcome of bacterialculture from mastoid granulations:is it relevant in chronicear disease[J], J Laryngol Otol,2005 ,119(10) ; 774-778.
5Kuczkowski J, Sakowicz-burkiewicz M, Izycka-swieszews-ka E,et al. Expression of tumor necrosis factor-a ? inter-leukin-1 a ,interleukin-6 and interleukin-10 in chronic otitismedia with bone osteolysis [J]. ORL J OtorhinolaryngolRelat Spec,2011,73(2):93-99.
6Sattar A, Alamgir A, Hussain Z,et al. Bacterial spectrumand their sensitivity pattern in patients of chronic suppu-rative otitis media[J]. J Coll Physicians Surg Pak,2012,22(2):128-129.
7Yeo SG,Park DC,Hong SM,et al. Bacteriology of chronicsuppurative otitis media-a multicenter study [J]. ActaOtolaryngol,2007,127(10) :1062-1067.
8Vishwanath S, Mukhopadhyay C,Prakash R,et al. Chron-ic suppurative otitis media : optimizing initial antibiotictherapy in a tertiary care setup [J]. Indian J OtolaryngolHead Neck Surg,2012,64(3) :285-289.
2Park CW,Tae K.Expression of RANKL and OPG in middle ear cholesteatoma tissue[J].Laryngoscope,2006,116(7):1180-1184.
3Clinical and laboratory Standards Institute.Performance Standards for Antimicrobial Susceptibility Testing:Twenty-First Informational Supplement[J].M100-S21,2011,31(1):21-143.
4Clinical and laboratory Standards Institute.Performance Standards for Antimicrobial Susceptibility Testing:Nineteenth Informational Supplement[J].M100-S19,2011,29(3):20-140.
5Khanna V,Chander J,Nagarkar NM.Clinicomicrobiologic evaluation of active tubotympanic type chronic suppurative otitis media[J].J Otolaryngol,2000,29(3):148-153.
8Van Bambeke F,Tulkens PM.Safety profile of the respiratory fluoroquinolone moxifloxacin:comparison with other fluoroquinolones and other antibacterial classes[J].Drug Saf,2009,32(5):359-378.
